DAX19.849 -0,2%ESt504.853 -0,2%Top 10 Crypto14,68 -3,3%Dow42.907 +0,2%Nas19.765 +1,0%Bitcoin90.571 -0,5%Euro1,0396 -0,1%Öl73,00 +0,1%Gold2.618 +0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Novo Nordisk A3EU6F Tesla A1CX3T Volkswagen (VW) vz. 766403 Palantir A2QA4J Rheinmetall 703000 Bayer BAY001 Amazon 906866 Mercedes-Benz Group (ex Daimler) 710000 MicroStrategy 722713 Apple 865985 Siemens Energy ENER6Y TUI TUAG50 BASF BASF11 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Ruhiger Wochenauftakt: DAX letztlich im Minus -- VW: Einigung im Tarifkonflikt -- BMW: Unregelmäßigkeiten bei Autoexporten -- Mercedes-Benz, BVB, AstraZeneca im Fokus
Top News
Unterschätzte Gefahr: BNP Paribas warnt Anleger vor Trumps Zollplänen Unterschätzte Gefahr: BNP Paribas warnt Anleger vor Trumps Zollplänen
Starker Wochentag in New York: NASDAQ Composite beendet den Handel in der Gewinnzone Starker Wochentag in New York: NASDAQ Composite beendet den Handel in der Gewinnzone
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

BioNTech (ADRs) Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
109,10 EUR +0,80 EUR +0,74 %
STU
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.26,06 Mrd. EUR

KGV25,25Div. Rendite0,00%

WKNA2PSR2

ISINUS09075V1026

SymbolBNTX

BioNTech (ADRs) Aktien News

DatumMeistgelesen
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaForecasting The Future: 15 Analyst Projections For BioNTech
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaGoogle DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
Financial TimesDeepMind and BioNTech build AI lab assistants for scientific research
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSSBioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
GlobeNewswireBioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSSPfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
GlobeNewswirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSSBioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
GlobeNewswireBioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaForecasting The Future: 8 Analyst Projections For BioNTech
ZacksBioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaGSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
RSSBioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024
GlobeNewswireBioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
BenzingaModerna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
Financial TimesThe Covid-era tech that could reinvent cancer care
RSSPfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
GlobeNewswirePfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
ZacksPfizer (PFE), BioNTech COVID-Flu Combo Shot Study Falters
BenzingaUnveiling 12 Analyst Insights On BioNTech
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSSPfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age

BioNTech (ADRs) News

BioNTech (ADRs) News: auf dieser Seite finden Sie alle BioNTech (ADRs) News und Nachrichten zur BioNTech (ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioNTech (ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioNTech (ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.